Buscar
01/04/2026
Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes
Cosio, MG, Severo, A, Gonzalez-Vilchez, F, Lopez-Vilella, R, Bueno, MG, Couto-Mallon, D, Blazquez, Z, Caravaca, P, Alarcos, H, Molina, BD, Romero, EG, Perez, SM, Marquez, MS, Bravo, IG, Tobar, J, Peiro, MB, Muñiz, J, Delgado, J. Timing of Lung Cancer Diagnosis After Heart Transplantation: Impact of Symptom Status on Stage, Treatment, and Outcomes. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Javier, I, Wypych-Zych, A, Jean-Baptiste, G, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Profiling Late Right Ventricular Failure Beyond 6 Months Post-LVAD Implantation: Phenotyping, Predictors, and Prognosis. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
01/04/2026
Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients
Bofarull, JG, Gallone, G, Thirupathirajan, V, Benedicto, AM, Ibero, J, Topciu, T, Guichard, J, Vella, MM, Saez, DG, Shanmuganathan, M, Fiorelli, F, Dar, O, Morley-Smith, A, Gil, FR. Hemodynamic Optimization and Hemocompatibility Outcomes in LVAD Recipients. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2026; 45(5)DOI:. PMID:. IF:6.000(Q1/1D).
23/03/2026
Editorial: Bridging translational gaps in cardiovascular disease through large animal research
Amorós-Figueras, G, Leite-Moreira, AM, Alogna, A, Fairweather, D. Editorial: Bridging translational gaps in cardiovascular disease through large animal research. Frontiers in Cardiovascular Medicine. 2026; 13DOI:10.3389/fcvm.2026.1824781. PMID:41948147. IF:2.900(Q2/4D).
01/05/2026
Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?
Bellofatto, IA, Nikolaou, PE, Andreadou, I, Canepa, M, Carbone, F, Ghigo, A, Heusch, G, Kleinbongard, P, Maack, C, Podesser, BK, Stamatelopoulos, K, Stellos, K, Vilahur, G, Montecucco, F, Liberale, L. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026; 115(5)DOI:10.1007/s00392-024-02522-2. PMID:39167195. IF:3.700(Q1/3D).
01/06/2023
Pitx2c deficiency confers cellular electrophysiological hallmarks of atrial fibrillation to isolated atrial myocytes
Tarifa, C, Serra, SA, Herraiz-Martinez, A, Lozano-Velasco, E, Benitez, R, Aranega, A, Franco, D, Hove-Madsen, L. Pitx2c deficiency confers cellular electrophysiological hallmarks of atrial fibrillation to isolated atrial myocytes. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2023; 162DOI:10.1016/j.biopha.2023.114577. PMID:37001181. IF:6.900(Q1/1D).